Dr. Olga María Rivero Martín

Emerging Investigator
Research Group on Psychiatry and Neurodegenerative Diseases

Presentation

Emerging
Investigator
Dr. Olga María Rivero Martín

olga.rivero@uv.es

Publications
Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients: what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?. Baeza I, de la Serna E, Mezquida G, Cuesta M, Vieta E, Amoretti S, Lobo A, Gonzalez-Pinto A, Diaz-Caneja C, Corripio I, Valli I, Puig O, Mane A, Bioque M, Ayora M, Bernardo M, Castro-Fornieles J, Balanza Martinez V, PEPs Grp. European Child & Adolescent Psychiatry. 2023 Apr 7. doi: 10.1007/s00787-023-02196-7. PMID: 37027026

T-cadherin is a novel regulator of pericyte function during angiogenesis. Dasen B, Pigeot S, Born G, Verrier S, Rivero O, Dittrich P, Martin I, Filippova M. American Journal of Physiology-Cell Physiology. 2023 Apr 1;324(4):C821-C836. doi: 10.1152/ajpcell.00326.2022. PMID: 36802732

The polygenic basis of relapse after a first episode of schizophrenia. Segura A, Prohens L, Gasso P, Rodriguez N, Garcia-Rizo C, Moreno-Izco L, Andreu-Bernabeu A, Zorrilla I, Mane A, Rodriguez-Jimenez R, Roldan A, Sarro S, Ibanez A, Usall J, Saiz P, Cuesta M, Parellada M, Gonzalez-Pinto A, Berrocoso E, Bernardo M, Mas S, Mezquida G, Arbelo N, De Matteis M, Galvan J, Duque Guerra A, Arias I Queralt L, Perez-Bacigalupe M, Gonzalez-Ortega I, Toll A, Casanovas F, Sanchez-Pastor L, Valtuena M, Pomarol-Clotet E, Garcia-Leon M, Butjosa A, Rubio-Abadal E, Ribeiro M, Lopez-Ilundain J, Saiz-Ruiz J, Leon-Quismondo L, Rivero O, Ruiz P, Echevarria R, Garcia-Portilla M. European Neuropsychopharmacology. 2023 Aug 19;75:80-92. doi: 10.1016/j.euroneuro.2023.06.003. PMID: 37603902

The role of BDNF and NGF plasma levels in first-episode schizophrenia: a longitudinal study. Martinez Pinteno A, Mezquida G, Bioque M, Lopez Ilundain JM, Andreu Bernabeu A, Zorrilla I, Mane A, Rodriguez Jimenez R, Corripio I, Sarro S, Ibanez A, Usall J, Rivero O, Gasso P, Leza JC, Cuesta MJ, Parellada M, Gonzalez Pinto A, Berrocoso E, Mas S, Bernardo M. European Neuropsychopharmacology. 2022 Feb 23;57:105-117. doi: 10.1016/j.euroneuro.2022.02.003. PMID: 35219096

Projects
Reference: PI22/01985
Title: Desarrollo y caracterización de nuevos modelos preclínicos celulares de medicina personalizada en psicosis
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Olga María Rivero Martín, Mª José Escartí Fabra
Duration: 2023 – 2025
Total budget: 117.370,00 €